Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_assertion description "[We argue that these new findings indicate that SPAK and OSR1 are promising drug targets for the treatment of hypertension, because inhibiting these enzymes would reduce NCC and NKCC2 activity and thereby suppress renal salt re-absorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_assertion evidence source_evidence_literature NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_assertion SIO_000772 18843116 NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_assertion wasDerivedFrom befree-20150227 NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_assertion wasGeneratedBy ECO_0000203 NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP889920.RA7gqrb044YIuLaXjjSgWYZSjcMv65nGnL01ekwY5nCe0130_provenance.